[REGN] YoY Quarter Result on 30-Sep-2014 [#Q3]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
04-Nov-2014
Financial Year
2014
Quarter
30-Sep-2014 [#Q3]
Profit Trend
QoQ- -14.03%
YoY- -43.58%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
Revenue 1,500,673 1,220,122 1,137,422 725,788 597,027 427,687 102,833 56.26%
PBT 565,605 365,881 393,289 176,078 225,684 191,468 -61,803 -
Tax 177,288 101,077 182,891 96,358 84,378 -517 562 160.68%
NP 388,317 264,804 210,398 79,720 141,306 191,468 -62,365 -
Tax Rate -31.34% -27.63% -46.50% -54.72% -37.39% 0.27% - -
Total Cost 1,112,356 955,318 927,024 646,068 455,721 236,219 165,198 37.37%
Ratio Analysis
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
NP Margin 25.88 21.70 18.50 10.98 23.67 44.77 -60.65 -
Per Share
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
EPS 3.64 2.53 2.04 0.83 1.44 2.02 -0.68 -
EPS Diluted 3.32 2.27 1.82 0.73 1.25 1.72 -0.68 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.